THE GLIOBLASTOMA FOUNDATION IS DEDICATED TO FINDING A CURE FOR GLIOBLASTOMA BY FUNDING RESEARCH AND DRUG DEVELOPMENT, SUPPORTING PATIENTS AND FAMILIES, AND RAISING NATIONAL AWARENESS OF THIS DEVASTATING BRAIN CANCER. THROUGH THESE INTEGRATED PROGRAMS, THE FOUNDATION ACCELERATES SCIENTIFIC DISCOVERY, EMPOWERS PATIENTS WITH INFORMATION AND RESOURCES, AND EDUCATES THE PUBLIC ABOUT THE URGENT NEED FOR BETTER TREATMENTS AND IMPROVED OUTCOMES.
Executive compensation, broken down
Form 990 · Schedule J · 1 reported individual · Filing year 2024
- Base
- $292k
- Bonus
- —
- Other
- —
- Benefits
- $29k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
CEO | $292k | — | — | $29k | $343k $364k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with BLS CPI-U for the South region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 4 unpaid individuals.
Up 2%
from 2023
From $336k in 2023 to $343k in 2024.
Estimated with BLS CPI-U for the South region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Revenue and expenses over time
GLIOBLASTOMA FOUNDATION INC reported revenue and expenses across 2 filing years.
What Medical Research executives earn
Comparable medical research organizations nationwide pay their highest-earning executive a median of $114,840.
These are medical research sector-wide figures, not this organization's reported pay. Based on 283 organizations across 283 filings (2021 – 2023).
See full Medical Research compensation data →Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.